Elite Pharmaceuticals Inc (ELTP)
0.1356
+0.01
(+7.41%)
USD |
OTCM |
May 10, 15:59
Elite Pharmaceuticals Free Cash Flow (Quarterly): -2.802M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.802M |
| September 30, 2023 | -0.2359M |
| June 30, 2023 | -2.710M |
| March 31, 2023 | 2.432M |
| December 31, 2022 | -0.5686M |
| September 30, 2022 | -3.610M |
| June 30, 2022 | -0.6521M |
| March 31, 2022 | 1.341M |
| December 31, 2021 | 2.952M |
| September 30, 2021 | 0.0064M |
| June 30, 2021 | 1.710M |
| March 31, 2021 | -0.9343M |
| December 31, 2020 | 1.185M |
| September 30, 2020 | 1.820M |
| June 30, 2020 | 0.7934M |
| March 31, 2020 | -1.238M |
| December 31, 2019 | -0.3122M |
| September 30, 2019 | -0.464M |
| June 30, 2019 | 0.1853M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.287M |
| September 30, 2018 | -1.501M |
| June 30, 2018 | -1.888M |
| March 31, 2018 | -0.9118M |
| December 31, 2017 | -0.3929M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.352M |
| June 30, 2017 | -1.427M |
| March 31, 2017 | -4.369M |
| December 31, 2016 | -1.019M |
| September 30, 2016 | -2.552M |
| June 30, 2016 | -1.049M |
| March 31, 2016 | 0.0356M |
| December 31, 2015 | -1.738M |
| September 30, 2015 | -4.186M |
| June 30, 2015 | 1.174M |
| March 31, 2015 | -4.455M |
| December 31, 2014 | -2.990M |
| September 30, 2014 | -4.757M |
| June 30, 2014 | -4.898M |
| March 31, 2014 | -1.602M |
| December 31, 2013 | -1.742M |
| September 30, 2013 | -1.024M |
| June 30, 2013 | -0.4091M |
| March 31, 2013 | -0.2477M |
| December 31, 2012 | -0.3709M |
| September 30, 2012 | -0.9508M |
| June 30, 2012 | -0.3286M |
| March 31, 2012 | 0.2281M |
| December 31, 2011 | -0.681M |
| September 30, 2011 | -0.6039M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.610M
Minimum
Sep 2022
2.952M
Maximum
Dec 2021
-0.0579M
Average
-0.2359M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.597M |
| Oragenics Inc | -1.102M |